Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsETFsIndustryCorrelations
Market CapEPSP/EP/SP/BSharesProfit MarginOperating MarginDebt to EquityRevenueEarningsEBITDAFree Cash FlowTotal DebtTotal AssetsROAROE

Beam Therapeutics (BEAM) Revenue (2019 - 2026)

Beam Therapeutics (BEAM) revenue from Mar 31, 2019 to Mar 31, 2026. The TTM Beam Therapeutics (BEAM) revenue is $164M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Revenue

Quarterly Revenue

Beam Therapeutics (BEAM) Revenue CAGR table

PeriodCAGR
1 Year TTM+157.97%
3 Years TTM+28.83%
5 Years TTM+427.92%
All Time TTM+300.20%

Annual Revenue change of Beam Therapeutics (BEAM)

YearRevenueChange
2026$32M-77.29%
2025$140M+119.99%
2024$64M-83.18%
2023$378M+520.01%
2022$61M+17.52%
2021$52M+259100.00%
2020$20KN/A
2019$20KN/A

Comparison Beam Therapeutics (BEAM) five years revenue CAGR with competitors

Beam Therapeutics (BEAM) five years revenue CAGR is 484.70%.

TickerNamefive years Revenue CAGRUpside
RYTMRhythm Pharmaceuticals Inc473.51%-2.31%
CRMDCorMedix Inc336.16%-30.64%
TGTXTG Therapeutics Inc278.04%-42.64%
GERNGeron Corp257.04%-46.97%
RVNCRevance Therapeutics Inc216.35%-55.36%
FENCFennec Pharmaceuticals Inc202.90%-58.14%
IBRXImmunityBio Inc200.12%-58.71%
ASNDAscendis Pharma A/S175.66%-63.76%
VXRTVaxart Inc174.17%-64.07%
AAPGAscentage Pharma Group International171.81%-64.55%
SNDXSyndax Pharmaceuticals Inc169.88%-64.95%
OCGNOcugen Inc153.09%-68.42%
BBIOBridgeBio Pharma Inc131.56%-72.86%
PRTAProthena Corporation plc131.47%-72.88%
CTXRCitius Pharmaceuticals Inc128.54%-73.48%
TLXTelix Pharmaceuticals Ltd123.87%-74.44%
PRQRProQR Therapeutics N.V121.71%-74.89%
BOLTBolt Biotherapeutics Inc121.10%-75.02%
PLURPluri Inc115.90%-76.09%
RPTXRepare Therapeutics Inc114.08%-76.46%
ATHEAlterity Therapeutics Ltd111.91%-76.91%
VRDNViridian Therapeutics Inc111.57%-76.98%
MRSNMersana Therapeutics Inc109.71%-77.36%
FHTXFoghorn Therapeutics Inc108.52%-77.61%
ARDXArdelyx Inc101.30%-79.10%
ARGXArgen X SE96.87%-80.02%
SEERSeer Inc - Class A94.78%-80.45%
ABUSArbutus Biopharma Corp90.98%-81.23%
GYREGyre Therapeutics Inc80.86%-83.32%
ENSCEnsysce Biosciences Inc79.79%-83.54%
TARSTarsus Pharmaceuticals Inc74.12%-84.71%
LEGNLegend Biotech Corp70.27%-85.50%
TRAWTraws Pharma Inc64.59%-86.67%
ADAGAdagene Inc61.38%-87.34%
CVACCureVac N.V.60.56%-87.51%
ADMAAdma Biologics Inc60.37%-87.55%
RXRXRecursion Pharmaceuticals Inc - Class A59.35%-87.76%
CGENCompugen Ltd57.53%-88.13%
ADAPAdaptimmune Therapeutics plc American Depositary Shares55.42%-88.57%
LCTXLineage Cell Therapeutics Inc54.06%-88.85%
CUECue Biopharma Inc53.77%-88.91%
MRKRMarker Therapeutics Inc53.28%-89.01%
IDYAIdeaya Biosciences Inc53.10%-89.05%
ALNYAlnylam Pharmaceuticals Inc49.77%-89.73%
FDMT4D Molecular Therapeutics Inc49.16%-89.86%
ZLABZai Lab Ltd49.02%-89.89%
URGNUroGen Pharma Ltd48.76%-89.94%
ARWRArrowhead Pharmaceuticals Inc47.49%-90.20%
ONCBeiGene Ltd46.08%-90.49%
ARCTArcturus Therapeutics Holdings Inc43.41%-91.04%
AUPHAurinia Pharmaceuticals Inc42.37%-91.26%
XBIOXenetic Biosciences Inc41.05%-91.53%
MNKDMannkind Corp40.31%-91.68%
ZVRAZevra Therapeutics Inc39.30%-91.89%
BRTXBioRestorative Therapies Inc38.99%-91.96%
IMRNImmuron Ltd38.57%-92.04%
MGTXMeiraGTx Holdings plc37.98%-92.16%
CPRXCatalyst Pharmaceuticals Inc37.80%-92.20%
HRMYHarmony Biosciences Holdings Inc37.73%-92.22%
INSMInsmed Inc37.33%-92.30%
HALOHalozyme Therapeutics Inc35.42%-92.69%
WVEWave Life Sciences Ltd35.16%-92.75%
APLSApellis Pharmaceuticals Inc34.55%-92.87%
ARVNArvinas Inc33.48%-93.09%
EVGNEvogene Ltd32.81%-93.23%
NBTXNanobiotix31.49%-93.50%
CRSPCRISPR Therapeutics AG30.10%-93.79%
NRIXNurix Therapeutics Inc29.16%-93.98%
SRPTSarepta Therapeutics Inc26.94%-94.44%
ANABAnaptysBio Inc26.67%-94.50%
VRCAVerrica Pharmaceuticals Inc25.37%-94.77%
LXRXLexicon Pharmaceuticals Inc24.38%-94.97%
NTRBNutriband Inc23.29%-95.20%
TVTXTravere Therapeutics Inc22.05%-95.45%
RANIRani Therapeutics Holdings Inc Class A21.08%-95.65%
FOLDAmicus Therapeutics Inc19.44%-95.99%
GLPGGalapagos NV19.11%-96.06%
ACADAcadia Pharmaceuticals Inc19.04%-96.07%
DYAIDyadic International Inc DE19.03%-96.07%
OCULOcular Therapeutix Inc18.64%-96.15%
EXELExelixis Inc18.17%-96.25%
VCELVericel Corp17.77%-96.33%
CORTCorcept Therapeutics Inc17.73%-96.34%
TNGXTango Therapeutics Inc17.63%-96.36%
RIGLRigel Pharmaceuticals17.49%-96.39%
NAGENiagen Bioscience Inc16.96%-96.50%
PTGXProtagonist Therapeutics Inc16.30%-96.64%
RAREUltragenyx Pharmaceutical Inc14.93%-96.92%
INCYIncyte Corp14.68%-96.97%
STROSutro Biopharma Inc14.67%-96.97%
MRUSMerus N.V14.54%-97.00%
PTCTPTC Therapeutics Inc13.95%-97.12%
VRTXVertex Pharmaceuticals Inc13.75%-97.16%
CELUCelularity Inc - Class A13.21%-97.27%
JAZZJazz Pharmaceuticals plc12.75%-97.37%
HRTXHeron Therapeutics Inc12.60%-97.40%
CYTKCytokinetics Inc12.56%-97.41%
BMRNBiomarin Pharmaceutical Inc11.94%-97.54%
OPTOpthea Ltd11.41%-97.65%
SPROSpero Therapeutics Inc11.22%-97.69%
PHARPharming Group N.V.10.70%-97.79%
TBPHTheravance Biopharma Inc10.63%-97.81%
ABVCABVC BioPharma Inc10.50%-97.83%
REGNRegeneron Pharmaceuticals Inc10.16%-97.90%
HCWBHCW Biologics Inc9.96%-97.94%
DAREDare Bioscience Inc9.62%-98.01%
MDXGMimedx Group Inc9.58%-98.02%
VALNValneva SE9.35%-98.07%
CSBRChampions Oncology Inc9.14%-98.12%
IONSIonis Pharmaceuticals Inc8.38%-98.27%
CYCNCyclerion Therapeutics Inc8.20%-98.31%
LGNDLigand Pharmaceuticals Inc - Class B8.15%-98.32%
FBIOFortress Biotech Inc8.13%-98.32%
SVASinovac Biotech Ltd7.99%-98.35%
AGENAgenus Inc7.88%-98.37%
ABEOAbeona Therapeutics Inc7.77%-98.40%
MGNXMacrogenics Inc7.76%-98.40%
PLXProtalix BioTherapeutics Inc7.76%-98.40%
TECHBio-Techne Corp7.39%-98.48%
CRDFCardiff Oncology Inc7.25%-98.50%
JAGXJaguar Health Inc7.22%-98.51%
CLLSCellectis6.98%-98.56%
CASICASI Pharmaceuticals Inc6.66%-98.62%
IGCIGC Pharma Inc6.63%-98.63%
ACIUAC Immune SA6.29%-98.70%
DTILPrecision Biosciences Inc6.03%-98.76%
CRBPCorbus Pharmaceuticals Holdings Inc5.98%-98.77%
KPTIKaryopharm Therapeutics Inc5.95%-98.77%
NTLAIntellia Therapeutics Inc5.11%-98.95%
IVAInventiva4.71%-99.03%
DNAGinkgo Bioworks Holdings Inc - Class A4.63%-99.05%
INVAInnoviva Inc4.13%-99.15%
ACRSAclaris Therapeutics Inc4.08%-99.16%
VTGNVistaGen Therapeutics Inc4.06%-99.16%
IMMPImmutep Ltd3.96%-99.18%
PGENPrecigen Inc3.45%-99.29%
IMTXImmatics N.V3.26%-99.33%
XNCRXencor Inc2.91%-99.40%
RPRXRoyalty Pharma plc - Class A2.82%-99.42%
ICCCImmucell Corp2.75%-99.43%
BNTXBioNTech SE2.17%-99.55%
LSTALisata Therapeutics Inc1.86%-99.62%
CDXSCodexis Inc1.52%-99.69%
HYFTMindWalk Holdings Corp1.38%-99.71%
KYMRKymera Therapeutics Inc0.86%-99.82%
ALECAlector Inc0.42%-99.91%